Efficacy and Safety of Bilateral Theta Burst Stimulation for the Treatment of Auditory Hallucinations (TBS-H)
Primary Purpose
Auditory Hallucinations
Status
Completed
Phase
Phase 2
Locations
Germany
Study Type
Interventional
Intervention
continuous theta burst stimulation (cTBS)
sham cTBS
Sponsored by
About this trial
This is an interventional treatment trial for Auditory Hallucinations
Eligibility Criteria
Inclusion Criteria:
- auditory hallucinations at least once a week
- Schizophrenia (DSM-IV)
- stable treatment setting (in- or out-patient)
- no change of antipsychotics during and at least 1 week before treatment initiation
Exclusion Criteria:
- epilepsy
- benzodiazepines > 1,5mg lorazepam / d
- pregnancy
- metal parts in the brain
- cardiac pacemaker
- deep brain stimulation
Sites / Locations
- University of Tübingen, Department of Psychiatry and Psychotherapy
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
cTBS
Sham cTBS
Arm Description
Outcomes
Primary Outcome Measures
Psychotic Symptom Rating Scales (PSYRATS), subscale for auditory hallucinations
Change of PSYRATS AH score compared to baseline after 3 weeks of treatment
Secondary Outcome Measures
Hallucination change score (HCS)
Positive and Negative Symptom Scale (PANSS)
PSYRATS subscale for auditory hallucinations
Change of PSYRATS AH score compared to baseline after 6 weeks of treatment
Full Information
NCT ID
NCT01478880
First Posted
November 21, 2011
Last Updated
July 13, 2013
Sponsor
University Hospital Tuebingen
1. Study Identification
Unique Protocol Identification Number
NCT01478880
Brief Title
Efficacy and Safety of Bilateral Theta Burst Stimulation for the Treatment of Auditory Hallucinations
Acronym
TBS-H
Official Title
Efficacy and Safety of Bilateral Repetitive Transcranial Magnetic Stimulation (Theta Burst Stimulation) for the Treatment of Auditory Hallucinations
Study Type
Interventional
2. Study Status
Record Verification Date
July 2013
Overall Recruitment Status
Completed
Study Start Date
May 2011 (undefined)
Primary Completion Date
July 2013 (Actual)
Study Completion Date
July 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital Tuebingen
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
First clinical studies indicate an effect of repetitive transcranial magnetic stimulation(rTMS) in the treatment of auditory hallucinations (AH). However, effect size, optimal stimulation site and parameters are unclear. With this randomized, placebo-controlled clinical trial we test the efficacy and safety of bilateral continuous theta burst stimulation (cTBS), a patterned form rTMS, against auditory hallucinations. The treatment will be applied add-on to individual antipsychotic and behavioral therapy. Patients will be treated for 6 weeks each weekday (30 sessions) with 40s of cTBS (halfway between T3/P3 and T4/P4). For weeks 1-3, half of the subjects will be randomized to a sham-stimulation (coil tilted 45°). During weeks 4-6, all subjects receive real cTBS.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Auditory Hallucinations
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
16 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
cTBS
Arm Type
Experimental
Arm Title
Sham cTBS
Arm Type
Sham Comparator
Intervention Type
Procedure
Intervention Name(s)
continuous theta burst stimulation (cTBS)
Intervention Description
bilateral continuous theta burst stimulation (bursts of 3 stimuli, 50Hz every 200ms for 40s, 80% active motor threshold) to the temporoparietal cortex (EEG 10/20: halfway T3/P3 and T4/P4)
Intervention Type
Procedure
Intervention Name(s)
sham cTBS
Intervention Description
bilateral continuous theta burst stimulation (bursts of 3 stimuli, 50Hz every 200ms for 40s, 80% active motor threshold) to the temporoparietal cortex (EEG 10/20: halfway T3/P3 and T4/P4) with the stimulation coil tilted 45°
Primary Outcome Measure Information:
Title
Psychotic Symptom Rating Scales (PSYRATS), subscale for auditory hallucinations
Description
Change of PSYRATS AH score compared to baseline after 3 weeks of treatment
Time Frame
3 weeks
Secondary Outcome Measure Information:
Title
Hallucination change score (HCS)
Time Frame
3 and 6 weeks
Title
Positive and Negative Symptom Scale (PANSS)
Time Frame
3 and 6 weeks
Title
PSYRATS subscale for auditory hallucinations
Description
Change of PSYRATS AH score compared to baseline after 6 weeks of treatment
Time Frame
6 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
auditory hallucinations at least once a week
Schizophrenia (DSM-IV)
stable treatment setting (in- or out-patient)
no change of antipsychotics during and at least 1 week before treatment initiation
Exclusion Criteria:
epilepsy
benzodiazepines > 1,5mg lorazepam / d
pregnancy
metal parts in the brain
cardiac pacemaker
deep brain stimulation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christian Plewnia, MD
Organizational Affiliation
Universtity of Tuebingen
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Tübingen, Department of Psychiatry and Psychotherapy
City
Tübingen
Country
Germany
12. IPD Sharing Statement
Learn more about this trial
Efficacy and Safety of Bilateral Theta Burst Stimulation for the Treatment of Auditory Hallucinations
We'll reach out to this number within 24 hrs